- J&J to acquire Intra-Cellular for approximately $14.6 billion Bloomberg
- Johnson & Johnson bets $15 billion on mental health drugs Market monitoring
- J&J to buy intracellular therapies for $14.6 billion CNBC
- Johnson & Johnson in $14.6 billion deal to buy intracellular biotechnology products Barron’s
- Johnson & Johnson in talks to buy neuroscience drugmaker Intra-Cellular for $10 billion Financial Times
